光正眼科(002524.SZ):完成出售哈密安迅達100%股權
格隆匯12月30日丨光正眼科(002524.SZ)公佈,公司於2020年12月25日召開第四屆董事會第三十八次會議,審議通過《關於擬出售哈密安迅達能源科技有限公司股權的議案》,同意公司全資子公司托克遜縣鑫天山燃氣有限公司(以下簡稱“鑫天山”)擬以1000萬元的價格出售其下屬子公司哈密安迅達能源科技有限公司(以下簡稱“哈密安迅達”)100%股權,並與受讓方簽署股權轉讓協議。
截至目前,鑫天山已依照股權轉讓協議的約定累計收到受讓方何騰、賴文鋼股權轉讓款833萬元,並辦理完畢出售哈密安迅達100%股權的交割相關手續。哈密安迅達的工商變更登記手續已於近日辦理完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.